Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.
Rallis G, Koletsa T, Saridaki Z, Manousou K, Koliou GA, Kostopoulos I, Kotoula V, Makatsoris T, Kourea HP, Raptou G, Chrisafi S, Samantas E, Papaparaskeva K, Pazarli E, Papakostas P, Kafiri G, Mauri D, Papoudou-Bai A, Christodoulou C, Petraki K, Dombros N, Pectasides D, Fountzilas G. Rallis G, et al. Among authors: makatsoris t. Anticancer Res. 2019 Apr;39(4):2129-2138. doi: 10.21873/anticanres.13326. Anticancer Res. 2019. PMID: 30952759
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Razis E, Skarlos D, Briasoulis E, Dimopoulos M, Fountzilas G, Lambropoulos S, Rigatos S, Kopterides P, Efstathiou H, Tzamakou E, Bakoyannis C, Pectasides D, Makatsoris T, Varthalitis G, Papadopoulos S, Kosmidis P. Razis E, et al. Among authors: makatsoris t. Anticancer Drugs. 2005 Feb;16(2):191-8. doi: 10.1097/00001813-200502000-00011. Anticancer Drugs. 2005. PMID: 15655417
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study.
Fountzilas G, Tolis C, Kalogera-Fountzila A, Karanikiotis C, Bai M, Misailidou D, Samantas E, Athanassiou E, Papamichael D, Tsekeris P, Catodritis N, Nicolaou A, Plataniotis G, Makatsoris T, Papakostas P, Zamboglou N, Daniilidis J. Fountzilas G, et al. Among authors: makatsoris t. Strahlenther Onkol. 2005 Apr;181(4):223-30. doi: 10.1007/s00066-005-1355-1. Strahlenther Onkol. 2005. PMID: 15827691 Clinical Trial.
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.
Makatsoris T, Kalofonos HP, Aravantinos G, Papadimitriou C, Kastritis E, Rigatos SK, Xiros N, Petsas T, Economopoulos T, Sakadamis AK, Fountzilas G; Hellenic Cooperative Oncology Group. Makatsoris T, et al. Int J Gastrointest Cancer. 2005;35(2):103-9. doi: 10.1385/ijgc:35:2:103. Int J Gastrointest Cancer. 2005. PMID: 15879624 Clinical Trial.
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Briasoulis E, Samantas E, Kalofonos H, Skarlos D, Makatsoris T, Christodoulou C, Fountzilas G, Bamias A, Dimopoulos MA, Kosmidis P, Pavlidis N. Briasoulis E, et al. Among authors: makatsoris t. Cancer Chemother Pharmacol. 2005 Nov;56(5):521-8. doi: 10.1007/s00280-004-0994-8. Epub 2005 Jun 15. Cancer Chemother Pharmacol. 2005. PMID: 15959778 Clinical Trial.
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Papakostas P, Dafni U, Makatsoris T, Karina M, Kalogera-Fountzila A, Maniadakis N, Aravantinos G, Syrigos K, Bamias A, Christodoulou C, Economopoulos T, Kalofonos H, Nikolaou A, Angouridakis N, Stathopoulos G, Bafaloukos D, Pavlidis N, Daniilidis J. Fountzilas G, et al. Among authors: makatsoris t. Ann Oncol. 2006 Oct;17(10):1560-7. doi: 10.1093/annonc/mdl151. Epub 2006 Jun 21. Ann Oncol. 2006. PMID: 16790517 Free article. Clinical Trial.
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.
Makatsoris T, Papakostas P, Kalofonos HP, Xanthakis I, Tsavdaridis D, Aravantinos G, Gogas H, Klouvas G, Kosmidis P, Pectasides D, Fountzilas G. Makatsoris T, et al. Med Oncol. 2007;24(3):301-7. doi: 10.1007/s12032-007-0004-1. Med Oncol. 2007. PMID: 17873305 Clinical Trial.
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Briasoulis E, Fountzilas G, Bamias A, Dimopoulos MA, Xiros N, Aravantinos G, Samantas E, Kalofonos H, Makatsoris T, Mylonakis N, Papakostas P, Skarlos D, Varthalitis I, Pavlidis N. Briasoulis E, et al. Among authors: makatsoris t. Cancer Chemother Pharmacol. 2008 Jul;62(2):277-84. doi: 10.1007/s00280-007-0604-7. Epub 2007 Sep 28. Cancer Chemother Pharmacol. 2008. PMID: 17901952 Clinical Trial.
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Kosmidis PA, Kalofonos HP, Christodoulou C, Syrigos K, Makatsoris T, Skarlos D, Bakogiannis C, Nicolaides C, Bafaloukos D, Bamias A, Samantas E, Xiros N, Boukovinas I, Fountzilas G, Dimopoulos MA. Kosmidis PA, et al. Among authors: makatsoris t. Ann Oncol. 2008 Jan;19(1):115-22. doi: 10.1093/annonc/mdm430. Epub 2007 Oct 15. Ann Oncol. 2008. PMID: 17938425 Free article. Clinical Trial.
87 results